Human papillomavirus genotype distribution in Madrid and correlation with cytological data

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Martín, Paloma ^a   Kilany, Linah ^a   García, Diego ^a   López García, Ana M ^a   Martin Azana M J ^a   Abraira, Victor ^b   Bellas, Carmen ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; BIOTINYLATION; CELL DAMAGE; CONTROLLED STUDY; DOT HYBRIDIZATION; DRUG EFFICACY; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; GENOTYPE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 81; INCIDENCE; INFECTION PREVENTION; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; SPAIN; STRAIN DIFFERENCE; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VACCINATION; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS; CLASSIFICATION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PREVALENCE; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPAIN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 81055148218     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-316     Document Type: Article

References (31)

1. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265. 10.1136/jcp.55.4.244, 1769629, 11919208.
2. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, . International Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of Human Papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527. 10.1056/NEJMoa021641, 12571259, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
3. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27. 10.1016/j.virol.2004.03.033, 15183049.
4. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003, 127:930-934.
5. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907. 10.1016/S0140-6736(07)61416-0, 17826171.
6. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM, Koutsky LA. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005, 191:731-738. 10.1086/427557, 15688287.
7. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003, 12:1029-1037.
8. Mejlhede N, Bonde J, Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 2009, 117:108-114. 10.1111/j.1600-0463.2008.00019.x, 19239432.
9. Soto-De Leon S, Camargo M, Sanchez R, Munoz M, Perez-Prados A, Purroy A, Patarroyo ME, Patarroyo MA. Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One 2011, 6:e14705. 10.1371/journal.pone.0014705, 3040737, 21379574.
10. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Van Doorn LJ. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345. 10.1128/JCM.40.9.3341-3345.2002, 130803, 12202576.
11. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004, 57:68-72. 10.1136/jcp.57.1.68, 1770158, 14693839.
12. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994, 170:1077-1085. 10.1093/infdis/170.5.1077, 7963696.
13. Coutlée F, Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H. Non isotopic detection and typing of human papillomavirus DNA in genital simples by the line blot assay. The Canadian Women's HIV study group. Clin Microbiol 1999, 37:1852-1857.
14. Dai Y, Huang YS, Tang M, Lv XP, Li TY, Yin YB. Distribution and clinical significance of human papillomavirus subtypes in Shenzhen city, People's Republic of China. Int J Gynecol Cancer 2008, 18:295-299. 10.1111/j.1525-1438.2007.01024.x, 17624987.
15. Otero-Motta AP, Ordoñez JL, Gonzalez-Celador R, Rivas B, García-Macias MC, Bullon A, Abad MM. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain. APMIS 2011, 119:204-215. 10.1111/j.1600-0463.2010.02711.x, 21284738.
16. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6:271-278. 10.1016/S1470-2045(05)70101-7, 15863374.
17. Gomez-Roman JJ, Echevarria C, Salas S, González-Morán MA, Perez-Mies B, García-Higuera I, Nicolás Martínez M, Val-Bernal JF. A type-specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions. APMIS 2009, 117:22-27. 10.1111/j.1600-0463.2008.00009.x, 19161533.
18. de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, Català I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003, 30:788-793. 10.1097/01.OLQ.0000080177.82204.E0, 14520179.
19. Cobo F, Concha A, Ortiz M. Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology. A correlation with histological study. Open Virol J 2009, 3:60-66. 10.2174/1874357900903010060, 2741607, 19750125.
20. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002, 89:229-240. 10.1016/S0168-1702(02)00191-0, 12445662.
21. Wu D, Cai L, Huang M, Zheng Y, Yu J. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. Eur J Obstet Gynecol 2010, 151:86-90.
22. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, . IARC HPV Prevalence Surveys Study Group Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998. 10.1016/S0140-6736(05)67069-9, 16168781, IARC HPV Prevalence Surveys Study Group.
23. Ripabelli G, Grasso GM, Del Riccio I, Tamburro M, Sammarco ML. Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, Central Italy. Cancer Epidemiol 2010, 34:162-167. 10.1016/j.canep.2009.12.010, 20080070.
24. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 2008, 17:2002-2006. 10.1158/1055-9965.EPI-08-0180, 18708390.
25. Capra G, Giovannelli L, Bellavia C, Migliore MC, Caleca MP, Perino A, Ammatuna P. HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res 2008, 133:195-200. 10.1016/j.virusres.2007.12.020, 18282628.
26. Conesa-Zamora P, Ortiz-Reina S, Moya-Biosca J, Doménech-Peris A, Orantes-Casado FJ, Pérez-Guillermo M, Egea-Cortines M. Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain. BMC Infect Dis 2009, 9:124. 10.1186/1471-2334-9-124, 2731031, 19664248.
27. Papachristou E, Sypsa V, Paraskevis D, Gkekas A, Politi E, Nicolaidou E, Anifantis I, Psichogiou M, Tsitsika A, Hadjivassiliou M, Petrikkos G, Katsambas A, Creatsas G, Hatzakis A. Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test. J Med Virol 2009, 81:2059-2065. 10.1002/jmv.21639, 19856480.
28. Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009, 9:191. 10.1186/1471-2334-9-191, 2789077, 19948015.
29. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997, 35:1304-1310. 229739, 9163434.
30. Schiffman M, Khan MJ, Solomon D, Herrero R, Wacholder S, Hildesheim A, Rodriguez AC, Bratti MC, Wheeler CM, Burk RD, . PEG Group; ALTS Group A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005, 97:147-150. 10.1093/jnci/dji014, 15657345, PEG Group; ALTS Group.
31. Krambeck WM, Cadide RM, Dalmarco EM, de Cordova CM. HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clin Exp Obstet Gynecol 2008, 35:175-178.